A carregar...
Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles
OBJECTIVE: The toxicity of anti-cancer chemotherapeutic agents can be reduced by associating these compounds, such as the anti-proliferative agent paclitaxel, with a cholesterol-rich nanoemulsion (LDE) that mimics the lipid composition of low-density lipoprotein (LDL). When injected into circulation...
Na minha lista:
| Publicado no: | Clinics (Sao Paulo) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4975788/ https://ncbi.nlm.nih.gov/pubmed/27626473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2016(08)05 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|